N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-N-(2-methylpropyl)-6-(trifluoromethyl)pyridine-3-carboxamide;N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-N-(thiophen-2-ylmethyl)pyridine-3-carboxamide;N-(cyclopropylmethyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-2-pyridinyl]pyridine-3-carboxamide;N-(cyclopropylmethyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-2-pyridinyl]-6-(trifluoromethyl)pyridine-3-carboxamide
C107H110F6N28O12S — CID 158007206
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-N-(2-methylpropyl)-6-(trifluoromethyl)pyridine-3-carboxamide;N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-N-(thiophen-2-ylmethyl)pyridine-3-carboxamide;N-(cyclopropylmethyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-2-pyridinyl]pyridine-3-carboxamide;N-(cyclopropylmethyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-2-pyridinyl]-6-(trifluoromethyl)pyridine-3-carboxamide
N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-N-(2-methylpropyl)-6-(trifluoromethyl)pyridine-3-carboxamide;N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-N-(thiophen-2-ylmethyl)pyridine-3-carboxamide;N-(cyclopropylmethyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-2-pyridinyl]pyridine-3-carboxamide;N-(cyclopropylmethyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-2-pyridinyl]-6-(trifluoromethyl)pyridine-3-carboxamide (PubChem CID 158007206) has the molecular formula C107H110F6N28O12S and a molecular weight of 2126.30 g/mol. Its IUPAC name is N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-N-(2-methylpropyl)-6-(trifluoromethyl)pyridine-3-carboxamide;N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-N-(thiophen-2-ylmethyl)pyridine-3-carboxamide;N-(cyclopropylmethyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-2-pyridinyl]pyridine-3-carboxamide;N-(cyclopropylmethyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-2-pyridinyl]-6-(trifluoromethyl)pyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-N-(2-methylpropyl)-6-(trifluoromethyl)pyridine-3-carboxamide;N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-N-(thiophen-2-ylmethyl)pyridine-3-carboxamide;N-(cyclopropylmethyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-2-pyridinyl]pyridine-3-carboxamide;N-(cyclopropylmethyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-2-pyridinyl]-6-(trifluoromethyl)pyridine-3-carboxamide |
|---|---|
| PubChem CID | 158007206 |
| Molecular Formula | C107H110F6N28O12S |
| Molecular Weight | 2126.30 g/mol |
| Exact Mass | 2124.85 |
| IUPAC Name | N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-N-(2-methylpropyl)-6-(trifluoromethyl)pyridine-3-carboxamide;N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-7H-purin-8-yl)-2-pyridinyl]-N-(thiophen-2-ylmethyl)pyridine-3-carboxamide;N-(cyclopropylmethyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-2-pyridinyl]pyridine-3-carboxamide;N-(cyclopropylmethyl)-N-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-2-pyridinyl]-6-(trifluoromethyl)pyridine-3-carboxamide |
| SMILES | CCCn1c(=O)c2[nH]c(-c3ccc(N(CC4CC4)C(=O)c4ccc(C(F)(F)F)nc4)nc3)nc2n(CCC)c1=O.CCCn1c(=O)c2[nH]c(-c3ccc(N(CC4CC4)C(=O)c4cccnc4)nc3)nc2n(CCC)c1=O.CCCn1c(=O)n(C2CC2)c(=O)c2[nH]c(-c3ccc(N(CC(C)C)C(=O)c4ccc(C(F)(F)F)nc4)nc3)nc21.CCCn1c(=O)n(C2CC2)c(=O)c2[nH]c(-c3ccc(N(Cc4cccs4)C(=O)c4cccnc4)nc3)nc21 |
| InChI | InChI=1S/2C27H28F3N7O3.C27H25N7O3S.C26H29N7O3/c1-4-11-35-23-21(25(39)37(26(35)40)18-7-8-18)33-22(34-23)16-6-10-20(32-12-16)36(14-15(2)3)24(38)17-5-9-19(31-13-17)27(28,29)30;1-3-11-35-23-21(25(39)36(12-4-2)26(35)40)33-22(34-23)17-8-10-20(32-13-17)37(15-16-5-6-16)24(38)18-7-9-19(31-14-18)27(28,29)30;1-2-12-32-24-22(26(36)34(27(32)37)19-8-9-19)30-23(31-24)17-7-10-21(29-15-17)33(16-20-6-4-13-38-20)25(35)18-5-3-11-28-14-18;1-3-12-31-23-21(25(35)32(13-4-2)26(31)36)29-22(30-23)18-9-10-20(28-15-18)33(16-17-7-8-17)24(34)19-6-5-11-27-14-19/h5-6,9-10,12-13,15,18H,4,7-8,11,14H2,1-3H3,(H,33,34);7-10,13-14,16H,3-6,11-12,15H2,1-2H3,(H,33,34);3-7,10-11,13-15,19H,2,8-9,12,16H2,1H3,(H,30,31);5-6,9-11,14-15,17H,3-4,7-8,12-13,16H2,1-2H3,(H,29,30) |
| InChIKey | FELBVBGFJNUYQY-UHFFFAOYSA-N |
| XLogP | 15.87 |
| TPSA | 475.08 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 154 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2126.30 |
| LogP ≤ 5 | 15.87 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 33 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158007206 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.